Crossmark Global Holdings, Inc. United Therapeutics Corp Transaction History

Crossmark Global Holdings, Inc.

  • $6.02 Billion
  • Q2 2025

A detailed history of Crossmark Global Holdings, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 3,485 shares of UTHR stock, worth $1.47 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,485
Previous 3,645 4.39%
Holding current value
$1.47 Million
Previous $1.12 Million 10.86%
% of portfolio
0.02%
Previous 0.02%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025
SELL
$276.47 - $328.4 $44,235 - $52,544
-160 Reduced 4.39%
3,485 $1 Million
Q1 2025

Apr 29, 2025
BUY
$304.42 - $380.78 $37,443 - $46,835
123 Added 3.49%
3,645 $1.12 Million
Q4 2024

Jan 16, 2025
SELL
$348.66 - $410.0 $21,616 - $25,420
-62 Reduced 1.73%
3,522 $1.24 Million
Q3 2024

Nov 04, 2024
BUY
$311.04 - $363.55 $189,112 - $221,038
608 Added 20.43%
3,584 $1.28 Million
Q2 2024

Jul 29, 2024
SELL
$228.26 - $319.04 $149,053 - $208,333
-653 Reduced 17.99%
2,976 $948,000
Q1 2024

May 13, 2024
BUY
$210.76 - $249.51 $13,067 - $15,469
62 Added 1.74%
3,629 $833,000
Q4 2023

Feb 13, 2024
SELL
$214.88 - $256.94 $97,770 - $116,907
-455 Reduced 11.31%
3,567 $784,000
Q3 2023

Nov 08, 2023
SELL
$211.82 - $248.24 $22,029 - $25,816
-104 Reduced 2.52%
4,022 $926,000
Q2 2023

Jul 31, 2023
SELL
$205.19 - $232.99 $54,170 - $61,509
-264 Reduced 6.01%
4,126 $1.01 Million
Q1 2023

May 12, 2023
BUY
$212.99 - $276.17 $28,540 - $37,006
134 Added 3.15%
4,390 $983,000
Q4 2022

Jan 19, 2023
BUY
$205.95 - $280.43 $5,354 - $7,291
26 Added 0.61%
4,256 $1.18 Million
Q3 2022

Nov 01, 2022
SELL
$203.3 - $244.17 $7,725 - $9,278
-38 Reduced 0.89%
4,230 $886,000
Q2 2022

Jul 29, 2022
SELL
$174.81 - $241.14 $153,832 - $212,203
-880 Reduced 17.09%
4,268 $1.01 Million
Q1 2022

May 11, 2022
SELL
$166.16 - $213.96 $83,080 - $106,980
-500 Reduced 8.85%
5,148 $923,000
Q4 2021

Jan 10, 2022
SELL
$184.32 - $216.08 $16,588 - $19,447
-90 Reduced 1.57%
5,648 $1.22 Million
Q3 2021

Oct 21, 2021
BUY
$179.86 - $214.88 $231,659 - $276,765
1,288 Added 28.94%
5,738 $1.06 Million
Q3 2021

Oct 13, 2021
BUY
$179.86 - $214.88 $90,289 - $107,869
502 Added 12.72%
4,450 $249,000
Q2 2021

Jul 21, 2021
SELL
$170.47 - $211.93 $20,456 - $25,431
-120 Reduced 2.95%
3,948 $708,000
Q1 2021

Apr 15, 2021
SELL
$153.94 - $174.85 $4,618 - $5,245
-30 Reduced 0.73%
4,068 $680,000
Q4 2020

Jan 14, 2021
SELL
$101.87 - $151.79 $9,168 - $13,661
-90 Reduced 2.15%
4,098 $622,000
Q3 2020

Oct 08, 2020
BUY
$99.9 - $121.13 $12,987 - $15,746
130 Added 3.2%
4,188 $423,000
Q2 2020

Aug 14, 2020
BUY
$92.74 - $125.82 $42,753 - $58,003
461 Added 12.82%
4,058 $491,000
Q1 2020

Apr 28, 2020
SELL
$79.39 - $115.35 $10,320 - $14,995
-130 Reduced 3.49%
3,597 $341,000
Q4 2019

Feb 06, 2020
BUY
$78.31 - $95.34 $4,698 - $5,720
60 Added 1.64%
3,727 $328,000
Q3 2019

Oct 09, 2019
SELL
$74.85 - $85.99 $13,472 - $15,478
-180 Reduced 4.68%
3,667 $292,000
Q2 2019

Jul 09, 2019
SELL
$76.06 - $120.81 $12,169 - $19,329
-160 Reduced 3.99%
3,847 $300,000
Q1 2019

May 02, 2019
BUY
$107.15 - $126.84 $7,500 - $8,878
70 Added 1.78%
4,007 $470,000
Q4 2018

Jan 31, 2019
SELL
$101.4 - $128.73 $119,652 - $151,901
-1,180 Reduced 23.06%
3,937 $429,000
Q3 2018

Nov 08, 2018
SELL
$113.81 - $129.46 $58,043 - $66,024
-510 Reduced 9.06%
5,117 $654,000
Q2 2018

Jul 31, 2018
BUY
$101.14 - $118.31 $16,182 - $18,929
160 Added 2.93%
5,627 $637,000
Q1 2018

Apr 16, 2018
SELL
$107.21 - $151.94 $104,529 - $148,141
-975 Reduced 15.14%
5,467 $614,000
Q4 2017

Feb 05, 2018
BUY
$118.58 - $151.28 $8,893 - $11,346
75 Added 1.18%
6,442 $953,000
Q3 2016

Oct 25, 2017
BUY
N/A
6,367
6,367 $746,000

Others Institutions Holding UTHR

# of Institutions
750
Shares Held
43.4M
Call Options Held
340K
Put Options Held
318K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $19.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Crossmark Global Holdings, Inc. Portfolio

Follow Crossmark Global Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email